Hudson Bay Capital Management Portfolio holdings
AUM
$15.2B
1-Year Return
11.47%
This Quarter Return
+8.91%
1 Year Return
+11.47%
3 Year Return
+62.45%
5 Year Return
+105.91%
10 Year Return
+214.7%
AUM
$11.4B
AUM Growth
+$6.42M
(+0.06%)
Cap. Flow
-$2.15B
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
861
New
198
Increased
118
Reduced
159
Closed
202
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$406M |
| 2 |
NVIDIA
NVDA
|
+$402M |
| 3 |
Tesla
TSLA
|
+$249M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$157M |
| 5 |
Apple
AAPL
|
+$144M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Amazon
AMZN
|
+$342M |
| 3 |
Advanced Micro Devices
AMD
|
+$336M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$243M |
Sector Composition
| 1 | Technology | 23.68% |
| 2 | Consumer Discretionary | 12.02% |
| 3 | Communication Services | 8.08% |
| 4 | Financials | 8.02% |
| 5 | Healthcare | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
APi Group
APG
$14.6B
| $785K | ﹤0.01% |
+30,000
| New | +$785K |
|
452
Douglas Elliman
DOUG
$253M
| $781K | ﹤0.01% |
494,401
| – | – |
|
453
Olema Pharmaceuticals
OLMA
$520M
| $764K | ﹤0.01% |
67,507
+5,007
| +8% | +$56.7K |
|
|
RCM
454
DELISTED
R1 RCM Inc. Common Stock
RCM
| $750K | ﹤0.01% |
+58,230
| New | +$750K |
|
455
Iovance Biotherapeutics
IOVA
$861M
| $741K | ﹤0.01% |
50,000
-225,000
| -82% | -$3.33M |
|
456
CarMax
KMX
$9.21B
| $740K | ﹤0.01% |
+8,500
| New | +$740K |
|
457
American Healthcare REIT
AHR
$7.21B
| $738K | ﹤0.01% |
+50,000
| New | +$738K |
|
458
Actinium Pharmaceuticals
ATNM
$49.9M
| $730K | ﹤0.01% |
+93,204
| New | +$730K |
|
459
EUDA Health Holdings
EUDA
$55.7M
| $720K | ﹤0.01% |
800,000
| – | – |
|
460
Metagenomi
MGX
$69.8M
| $703K | ﹤0.01% |
+66,666
| New | +$703K |
|
461
REV Group
REVG
$3.03B
| $663K | ﹤0.01% |
+30,000
| New | +$663K |
|
462
NCR Atleos
NATL
$2.95B
| $617K | ﹤0.01% |
31,261
| – | – |
|
463
Cellectar Biosciences
CLRB
$16.1M
| $597K | ﹤0.01% |
+5,000
| New | +$597K |
|
464
Estee Lauder
EL
$32B
| $581K | ﹤0.01% |
3,767
+179
| +5% | +$27.6K |
|
465
Intel
INTC
$114B
| $563K | ﹤0.01% |
12,754
-887,246
| -99% | -$39.2M |
|
|
ENFN
466
DELISTED
Enfusion, Inc.
ENFN
| $563K | ﹤0.01% |
+60,865
| New | +$563K |
|
|
LUNA
467
DELISTED
Luna Innovations Incorporated
LUNA
| $561K | ﹤0.01% |
+175,000
| New | +$561K |
|
|
EXEEL
468
Expand Energy Corporation Class C Warrants
EXEEL
| $532K | ﹤0.01% |
+7,322
| New | +$532K |
|
469
ADT
ADT
$7.07B
| $493K | ﹤0.01% |
+73,320
| New | +$493K |
|
470
Workhorse Group
WKHS
$18.4M
| $483K | ﹤0.01% |
+8,448
| New | +$483K |
|
471
Microbot Medical
MBOT
$218M
| $483K | ﹤0.01% |
+402,386
| New | +$483K |
|
472
Pharvaris
PHVS
$1.4B
| $463K | ﹤0.01% |
20,018
-50,116
| -71% | -$1.16M |
|
473
Intelligent Bio Solutions
INBS
$14.8M
| $457K | ﹤0.01% |
+108,250
| New | +$457K |
|
474
NextCure
NXTC
$13.2M
| $454K | ﹤0.01% |
+16,983
| New | +$454K |
|
|
LUNRW
475
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
| $438K | ﹤0.01% |
+250,000
| New | +$438K |
|